Authors
Earlier this month, Turquoise Health submitted a public comment in response to CMS-1786-P, the 2024 OPPS Proposed Rule that included new hospital price transparency improvements and requirements.
We focused our feedback on section XVIII of the act, “Proposed Updates to Requirements for Hospitals to Make Public a List of Their Standard Charges.”
Turquoise is in full support of CMS’ commitment to continued improvement and iteration of Hospital Price Transparency requirements. While Turquoise has observed a significant uptick in MRF disclosures from 2021 to 2023, the MRFs are still plagued by schema inconsistencies and missing contents that are hard to police with automation. These shortcomings also limit the utility of existing macroeconomic and microeconomic applications.
The proposed requirement to mandate a standardized schema for hospital MRFs is critical and urgent to address the issues with data utility. We are in agreement with this update.
Our full comment can be summarized as follows:
- We iterate our strong support as a leading third-party innovator in the industry for all of the newly proposed disclosure requirements
- We ask for clarification around two finer details of the newly required hospital MRF schema
- We close with thematic suggestions for continued regulatory iteration on behalf of consumers, either through the Final Rule or in subsequent rulemaking
Related resources
Learn, listen, and watch the latest on price transparency.
Transparency in Coverage Final Rule (2026): What Changes for Payer Machine-Readable Files
Payers will report by network instead of plan, move from monthly to quarterly, and attest to their data. We expect files to be slimmed down, more organized, and easier to find online.
Prescription Drugs Rates Get A Mandated Due Date with Dec 2027 Enforcement
What this means for manufacturers ability to provide patients a personalized OOP cost for drugs
Transparency in Coverage Update Trims Down Payer MRFs & Brings Back the Rx File
CMS's first major TiC overhaul since 2022 simplifies payer files and sets a December 2027 enforcement date for the prescription drug file. Here's what it means for patients and the industry